(Photo: PTI)

9.36 am: Aurobindo Pharma shares rose over 3 per cent to Rs 779.70 in the early trade on BSE after the company on August 29 said it has received the final approval from the US Food & Drug Administration to manufacture and market Raloxifene Hydrochloride Tablets USP 60mg. Sensex was down 132.95 points at 26,259. NSE Nifty was down 35.30 points at 7,967.

9.26 am: Sensex was down 158.78 points at 26,233.60.

Domestic equity markets opened in green on Monday. The BSE Sensex and NSE Nifty opened 77.04 points and 7.3 points higher at 26,469.42 and 8009.25, respectively.

Shares of healthcare and information technology were trading in positive zone in the early trade.

Asian stocks fell on Monday after a US Federal Reserve official suggested a September interest rate hike still was possible and Japanese factory activity weakened.

The Shanghai Composite Index fell 2 per cent to 3,167.76 and Tokyo’s Nikkei 225 shed 1.1 per cent 18,920.90. Hong Kong’s Hang Seng retreated 0.3 per cent to 21,539.59.

(With inputs from agencies)